The emergence of a novel vaccine can be both a scientific triumph and point of uncertainty for the general population. Dr. Robert Jackson, a postdoctoral fellow in the laboratory of Dr. Koenraad Van Doorslaer, discusses his research on human papillomavirus - the most common sexually transmitted virus and cause of 5% of all cancers worldwide. Dr. Jackson, a recipient of the BIO5 and Canadian NSERC Postdoctoral Fellowships, also talks about his passion for communicating the scientific method, or process, to the public, specifically as it relates to sharing the utilities of both the HPV and COVID-19 vaccines.